Peroxisome Proliferator-Activated Receptor-Targeted Therapies: Challenges upon Infectious Diseases.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
17 02 2023
Historique:
received: 09 12 2022
revised: 13 02 2023
accepted: 14 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

Peroxisome proliferator-activated receptors (PPARs) α, β, and γ are nuclear receptors that orchestrate the transcriptional regulation of genes involved in a variety of biological responses, such as energy metabolism and homeostasis, regulation of inflammation, cellular development, and differentiation. The many roles played by the PPAR signaling pathways indicate that PPARs may be useful targets for various human diseases, including metabolic and inflammatory conditions and tumors. Accumulating evidence suggests that each PPAR plays prominent but different roles in viral, bacterial, and parasitic infectious disease development. In this review, we discuss recent PPAR research works that are focused on how PPARs control various infections and immune responses. In addition, we describe the current and potential therapeutic uses of PPAR agonists/antagonists in the context of infectious diseases. A more comprehensive understanding of the roles played by PPARs in terms of host-pathogen interactions will yield potential adjunctive personalized therapies employing PPAR-modulating agents.

Identifiants

pubmed: 36831317
pii: cells12040650
doi: 10.3390/cells12040650
pmc: PMC9954612
pii:
doi:

Substances chimiques

Receptors, Cytoplasmic and Nuclear 0
PPAR alpha 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Curr Med Chem. 2005;12(25):2995-3009
pubmed: 16378501
Am J Respir Cell Mol Biol. 2008 Dec;39(6):689-96
pubmed: 18566335
Parasite Immunol. 2021 Jan;43(1):e12783
pubmed: 32734677
Nature. 2008 Nov 20;456(7220):350-6
pubmed: 19043829
FEBS J. 2020 Aug;287(16):3350-3369
pubmed: 32255251
Front Pharmacol. 2022 Jul 18;13:916866
pubmed: 35924060
Elife. 2021 May 12;10:
pubmed: 33978570
Front Immunol. 2020 Jan 09;10:2955
pubmed: 31993046
J Lipid Res. 2014 Aug;55(8):1702-10
pubmed: 24927728
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0148921
pubmed: 34748384
Physiol Rev. 1966 Apr;46(2):323-57
pubmed: 5325972
J Biol Chem. 2010 Dec 24;285(52):40409-15
pubmed: 20956526
Cell Rep. 2022 Jun 7;39(10):110910
pubmed: 35675775
Viruses. 2019 Jun 01;11(6):
pubmed: 31159430
J Gastroenterol. 2021 Feb;56(2):168-180
pubmed: 33211179
J Biol Chem. 1995 Jul 7;270(27):16114-21
pubmed: 7608174
Biochemistry. 2003 Sep 16;42(36):10726-35
pubmed: 12962497
Viral Immunol. 2010 Aug;23(4):343-52
pubmed: 20712478
Cell Rep. 2022 Jan 25;38(4):110284
pubmed: 35081341
Mol Endocrinol. 1997 Jun;11(6):779-91
pubmed: 9171241
mBio. 2021 Jan 19;12(1):
pubmed: 33468700
Oncotarget. 2017 Feb 7;8(6):9053-9066
pubmed: 28118607
Crit Rev Toxicol. 1983;12(1):1-58
pubmed: 6360536
PLoS Negl Trop Dis. 2020 Oct 19;14(10):e0008850
pubmed: 33075048
Cell. 1992 Mar 6;68(5):879-87
pubmed: 1312391
Proc Natl Acad Sci U S A. 1986 Mar;83(6):1747-51
pubmed: 3456610
Emerg Microbes Infect. 2020 Dec;9(1):2046-2060
pubmed: 32873194
Metabolism. 2021 Jan;114:154338
pubmed: 32791172
Front Immunol. 2021 Apr 13;12:658715
pubmed: 33927725
Res Commun Chem Pathol Pharmacol. 1975 Mar;10(3):589-92
pubmed: 1135523
Eur J Med Chem. 2019 Mar 15;166:502-513
pubmed: 30739829
Endocr Rev. 1999 Oct;20(5):649-88
pubmed: 10529898
J Biol Chem. 2000 Nov 24;275(47):36703-7
pubmed: 10980195
Nature. 1998 Jun 25;393(6687):790-3
pubmed: 9655393
Nature. 1998 Sep 10;395(6698):137-43
pubmed: 9744270
Proc Natl Acad Sci U S A. 2019 Dec 3;116(49):24819-24829
pubmed: 31740620
Front Pharmacol. 2020 Nov 06;11:589438
pubmed: 33240092
Circ Res. 1999 Sep 3;85(5):394-402
pubmed: 10473669
Biochim Biophys Acta. 2015 May;1852(5):893-904
pubmed: 25557389
Nutr J. 2014 Feb 14;13:17
pubmed: 24524207
J Cell Physiol. 2018 Jan;233(1):153-161
pubmed: 28098353
Biochim Biophys Acta. 2007 Aug;1771(8):926-35
pubmed: 17433773
Trends Biochem Sci. 2016 May;41(5):460-471
pubmed: 26935843
Sci Immunol. 2017 Mar 10;2(9):
pubmed: 28783701
Biochim Biophys Acta. 2011 Aug;1812(8):824-35
pubmed: 21193032
Front Immunol. 2021 Dec 22;12:783780
pubmed: 35003101
Signal Transduct Target Ther. 2021 Jun 4;6(1):210
pubmed: 34083514
Biochimie. 2017 May;136:90-99
pubmed: 27916645
J Immunol. 2006 Mar 1;176(5):3087-97
pubmed: 16493068
Malar J. 2020 Oct 21;19(1):376
pubmed: 33087130
Endocrinology. 1996 Jan;137(1):354-66
pubmed: 8536636
J Biol Chem. 1998 Oct 2;273(40):25573-80
pubmed: 9748221
Mol Endocrinol. 1992 Oct;6(10):1634-41
pubmed: 1333051
Nature. 1999 Nov 4;402(6757):93-6
pubmed: 10573424
Nat Rev Microbiol. 2021 Jul;19(7):467-480
pubmed: 33627834
Immunity. 2021 Jan 12;54(1):19-31
pubmed: 33220233
Viruses. 2018 Jan 30;10(2):
pubmed: 29385741
Mol Carcinog. 2017 May;56(5):1472-1483
pubmed: 27996177
Mol Cell Endocrinol. 2021 Jan 15;520:111095
pubmed: 33253762
Nat Rev Immunol. 2002 Oct;2(10):748-59
pubmed: 12360213
J Biol Chem. 1993 Dec 25;268(36):26817-20
pubmed: 8262913
Nature. 1998 Jan 1;391(6662):79-82
pubmed: 9422508
PPAR Res. 2010;2010:
pubmed: 20814439
J Adv Pharm Technol Res. 2011 Oct;2(4):236-40
pubmed: 22247890
J Immunol. 2018 Apr 15;200(8):2677-2689
pubmed: 29514950
Cell. 2016 Sep 8;166(6):1512-1525.e12
pubmed: 27610573
PPAR Res. 2015;2015:549691
pubmed: 26713087
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4653-7
pubmed: 1316614
J Clin Invest. 1999 Jun;103(11):1489-98
pubmed: 10359558
Lancet. 2010 Apr 17;375(9723):1388-402
pubmed: 20399979
Front Pharmacol. 2019 Oct 25;10:1270
pubmed: 31708789
Virol J. 2017 May 25;14(1):96
pubmed: 28545573
iScience. 2020 Oct 23;23(11):101727
pubmed: 33205029
Biochem Soc Trans. 2011 Dec;39(6):1601-5
pubmed: 22103494
J Immunol. 2010 Jul 15;185(2):929-42
pubmed: 20554962
Med Microbiol Immunol. 2019 Oct;208(5):651-666
pubmed: 30413884
Int J Mol Sci. 2018 Jun 12;19(6):
pubmed: 29895749
Annu Rev Physiol. 2007;69:201-20
pubmed: 17137423
PPAR Res. 2009;2009:925309
pubmed: 20052392
Immunol Rev. 2017 Jul;278(1):237-245
pubmed: 28658549
Commun Biol. 2022 Mar 14;5(1):231
pubmed: 35288651
Exp Parasitol. 2016 Nov;170:100-108
pubmed: 27693222
PLoS Negl Trop Dis. 2020 Jul 9;14(7):e0008470
pubmed: 32644998
Int J Mol Sci. 2021 Aug 18;22(16):
pubmed: 34445581
J Pathol. 2011 Aug;224(4):575-88
pubmed: 21598253
Protein Sci. 2018 Nov;27(11):1876-1892
pubmed: 30109749
Nature. 1990 Oct 18;347(6294):645-50
pubmed: 2129546
J Hepatol. 2019 May;70(5):963-973
pubmed: 30677458
J Virol. 2019 Apr 17;93(9):
pubmed: 30787149
Clin Exp Immunol. 2022 May 12;207(3):370-377
pubmed: 35553637
Int J Mol Sci. 2021 Jul 15;22(14):
pubmed: 34299217
J Parasitol. 2021 Mar 1;107(2):205-213
pubmed: 33684197
Nat Rev Cancer. 2012 Feb 09;12(3):181-95
pubmed: 22318237
Semin Cell Dev Biol. 2012 Aug;23(6):631-9
pubmed: 22273692
Nat Rev Dis Primers. 2018 Aug 9;4(1):13
pubmed: 30093684
J Parasitol. 2020 Oct 1;106(5):564-571
pubmed: 32916705
Proc Natl Acad Sci U S A. 2020 Jul 7;117(27):15789-15798
pubmed: 32581129
Cancer Lett. 2010 Feb 28;288(2):219-25
pubmed: 19660859
Immunobiology. 2017 Apr;222(4):604-619
pubmed: 27887739
Adv Exp Med Biol. 2020;1299:3-17
pubmed: 33417203
J Immunol. 2009 Jul 15;183(2):1337-45
pubmed: 19561094
J Exp Med. 2021 Oct 4;218(10):
pubmed: 34406362
Lancet. 2006 Sep 23;368(9541):1106-18
pubmed: 16997665
J Immunol. 2017 Apr 15;198(8):3283-3295
pubmed: 28275133
Med Hypotheses. 2020 Oct;143:110197
pubmed: 33017906
Inflamm Res. 2022 Nov;71(10-11):1159-1167
pubmed: 35941297
Biochemistry. 1993 Jun 1;32(21):5598-604
pubmed: 7684926
Infect Immun. 2014 Aug;82(8):3333-40
pubmed: 24866800
PLoS Pathog. 2020 Dec 16;16(12):e1009127
pubmed: 33326472
Adv Exp Med Biol. 2019;1127:39-57
pubmed: 31140170
Am J Clin Nutr. 1995 Nov;62(5 Suppl):1086S-1095S
pubmed: 7484926
Exp Parasitol. 2017 Jul;178:37-44
pubmed: 28527905
Biomed Res Int. 2021 Sep 9;2021:9066938
pubmed: 34540999
PLoS One. 2012;7(9):e46009
pubmed: 23049921
Front Cell Infect Microbiol. 2022 Jul 04;12:881462
pubmed: 35860381
JAMA Pediatr. 2020 Mar 1;174(3):269-276
pubmed: 31904798
Cells. 2020 Mar 06;9(3):
pubmed: 32155958
J Biol Chem. 1987 Jan 15;262(2):801-10
pubmed: 3027069
Cell Mol Immunol. 2016 Jan;13(1):3-10
pubmed: 26189369
Front Immunol. 2021 Feb 15;12:599345
pubmed: 33659001
Int J Clin Pharmacol Ther. 1998 Jun;36(6):345-9
pubmed: 9660044
Gut. 2016 Jul;65(7):1202-14
pubmed: 26838599
PLoS One. 2019 Oct 4;14(10):e0223430
pubmed: 31584978
PLoS One. 2016 Mar 22;11(3):e0152022
pubmed: 27003162
Gene Expr. 1995;4(4-5):281-99
pubmed: 7787419
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):829-831
pubmed: 32540737
J Immunol. 2012 Jun 1;188(11):5593-603
pubmed: 22544925
Mol Cell Biochem. 2008 Oct;317(1-2):189-96
pubmed: 18600431
J Neuroinflammation. 2017 Sep 8;14(1):183
pubmed: 28886715
Respir Res. 2021 Aug 19;22(1):230
pubmed: 34412637
Nat Med. 2004 Apr;10(4):355-61
pubmed: 15057233
Cell Microbiol. 2021 Nov;23(11):e13390
pubmed: 34464019
Pharmacol Res. 2016 Sep;111:76-85
pubmed: 27268145
Phytother Res. 2021 Dec;35(12):6893-6903
pubmed: 34643000
Mol Cell Biol. 1995 Mar;15(3):1817-25
pubmed: 7862171
Eur J Pharmacol. 2016 Aug 15;785:44-49
pubmed: 26632493
Biochem Soc Trans. 2006 Dec;34(Pt 6):1341-6
pubmed: 17073815
Microb Pathog. 2021 Dec;161(Pt B):105284
pubmed: 34767930
J Hepatol. 2011 Nov;55(5):963-71
pubmed: 21354229

Auteurs

In Soo Kim (IS)

Department of Microbiology, College of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.
Department of Medical Science, College of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.
Infection Control Convergence Research Center, College of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.

Prashanta Silwal (P)

Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.

Eun-Kyeong Jo (EK)

Department of Microbiology, College of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.
Department of Medical Science, College of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.
Infection Control Convergence Research Center, College of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH